Investing Profile

Elena Viboch

InvestorVC
Partner at General Catalyst
generalcatalyst.comSan Francisco Bay Area
Photo of Elena Viboch, Partner at General Catalyst
Your Intro Paths to Elena Viboch

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Elena Viboch's investing connections

Picture
Picture

2 Investors

Connected to Saar Gur (CRV), Lisa Marrone (August Capital).

Find Elena Viboch on

cb
Current Investing Position
General Catalyst Partner
Investment Range
$500K - $2.0M
Sweet Spot
$500K
Investments On Record
22
Current Fund Size
$1.1B

Elena Viboch is on these Sector & Stage Rankings

Elena Viboch's Investments On Record (18)

CompanyStageDateRound SizeTotal Raised
Chai Discovery
Series BDec 2025$130M
$230M
Co-investors: Fred Ehrsam (Paradigm), Hemant Taneja (General Catalyst), Greg Yap (Menlo Ventures), Nitesh Banta (Stellar Capital), Lachy Groom (LGF), Annie Lamont (Oak HC/FT)
Paradigm
Series BDec 2025$78M
Series AJan 2023$200M
$320M
Co-investors: Ramnik Arora (FTX Ventures), Hemant Taneja (General Catalyst), Niko Bonatsos (General Catalyst), Bilal Zuberi (Lux Capital), Brett Cook (F-Prime Capital Partners), Stephen Knight (F-Prime Capital Partners), Jay Markowitz (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners), Jared Friedman (Y Combinator), Justin Kao (DFJ Growth), Alaa Halawa (Mubadala), Arash Ferdowsi, Scott Belsky, Eoghan McCabe, Karim Atiyeh, Balaji Srinivasan
Maxion Therapeutics
Series AMar 2025$75M
$91M
Co-investors: Lucy Edwardes-Jones (Business Growth Fund)
Eikon Therapeutics
Series DFeb 2025$350M
Series BJan 2022$520M
$1B
Co-investors: Josh Wolfe (Lux Capital), Leon Chen (The Column Group), Adam Goulburn (Dimension Capital), Larry Lasky (The Column Group), Dror Berman (Innovation Endeavors), Eric Schmidt (Innovation Endeavors)
Manas AI
SeedJan 2025$26M
$26M
Co-investors: Reid Hoffman (Greylock)
Medeloop
Series ANov 2024$16M
SeedSep 2023$8M
$24M
Co-investors: Sara Thomas Deshpande (Maven Ventures), Magaly Charbonneau (iNovia Capital)
Alpha-9 Oncology
Series COct 2024$180M
$250M
Co-investors: Patrick Heron (Frazier Healthcare Partners), Melissa McCracken (Nextech Invest), Cory Freedland (Samsara BioCapital)
Elektrofi
Series CAug 2024$110M
$110M